Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | 07/06/2026 | Verkauf | 87.03 | 2,474 | 215,312 | Form 4 |
| PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | 07/06/2026 | Optionsausübung | 39.42 | 2,474 | 97,525 | Form 4 |
| PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | 07/06/2026 | Verkauf | 86.32 | 10,090 | 870,969 | Form 4 |
| PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | 07/06/2026 | Verkauf | 85.35 | 8,786 | 749,885 | Form 4 |
| PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | 07/06/2026 | Optionsausübung | 38.10 | 18,876 | 719,176 | Form 4 |
| PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | 07/06/2026 | Verkauf | 86.34 | 385 | 33,241 | Form 4 |
| PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | 07/06/2026 | Verkauf | 85.28 | 426 | 36,329 | Form 4 |
| PTCT | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | 07/06/2026 | Optionsausübung | 38.10 | 811 | 30,899 | Form 4 |
| PB | Franklin Robert R Jr | Vice Chairman | 07/06/2026 | Zuteilung | — | 25,000 | — | Form 4 |
| PBF | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | 07/06/2026 | Verkauf | 49.52 | 150,000 | 7,428,165 | Form 4 |
| PBF | Control Empresarial de Capitales S.A. de C.V. | 10% Owner | 07/06/2026 | Verkauf | 48.00 | 50,000 | 2,400,045 | Form 4 |
| PRTH | Crisafulli Marc A | Director | 07/01/2026 | Optionsausübung | — | 4,296 | — | Form 4 |
| PRTH | Favilla Christina M | Director | 07/01/2026 | Verkauf | 6.67 | 1,229 | 8,197 | Form 4 |
| PRTH | Favilla Christina M | Director | 07/01/2026 | Optionsausübung | — | 4,296 | — | Form 4 |
| PRTH | Passilla Michael | Director | 07/01/2026 | Verkauf | 6.67 | 1,168 | 7,791 | Form 4 |
| PRTH | Passilla Michael | Director | 07/01/2026 | Optionsausübung | — | 4,296 | — | Form 4 |
| PRTH | Davis Marietta | Director | 07/01/2026 | Verkauf | 6.67 | 1,168 | 7,791 | Form 4 |
| PRTH | Davis Marietta | Director | 07/01/2026 | Optionsausübung | — | 4,296 | — | Form 4 |
| PRTH | Main Clayton James | Director | 07/01/2026 | Optionsausübung | — | 4,296 | — | Form 4 |
| PAYS | Mina Bruce A | Director | 06/11/2026 | Verkauf | 7.10 | 10,000 | 70,950 | Form 4 |
| PAYS | Mina Bruce A | Director | 06/01/2026 | Verkauf | 7.10 | 10,000 | 71,000 | Form 4 |
| PAYS | Triplett Dennis L | Director | 05/08/2026 | Zuteilung | — | 20,000 | — | Form 4 |
| PAYS | Newman Jeffrey B | Director | 05/08/2026 | Zuteilung | — | 20,000 | — | Form 4 |
| PAYS | Mina Bruce A | Director | 05/08/2026 | Zuteilung | — | 20,000 | — | Form 4 |
| PAYS | Henry Daniel R | Director | 05/08/2026 | Zuteilung | — | 20,000 | — | Form 4 |
| PLBY | Bernhard L Kohn III | CEO | 04/24/2026 | Verkauf | 1.83 | 18,502 | 33,859 | Form 4 |
| PLBY | Christopher Riley | General Counsel | 04/24/2026 | Verkauf | 1.82 | 8,916 | 16,227 | Form 4 |
| PMI | Michael Patrick O'Shea | Insider | 04/24/2026 | Kauf | — | 4,463 | — | — |
| PMI | Piers Godfrey Harrison | Insider | 04/24/2026 | Kauf | — | 4,463 | — | — |
| PCRX | Shawn Cross | CFO | 04/23/2026 | Verkauf | 25.16 | 12,941 | 325,596 | Form 4 |
| PEBK | James S Abernethy | Director | 04/23/2026 | Verkauf | 40.06 | 600 | 24,036 | Form 4 |
| PHVS | Anne Lesage | Insider | 04/23/2026 | Verkauf | 30.03 | 100 | 3,003 | Form 4 |
| PHVS | Johannes Gerardus Chri Schikan | Director | 04/23/2026 | Verkauf | 30.03 | 100 | 3,003 | Form 4 |
| PHVS | Peng Lu | Insider | 04/23/2026 | Verkauf | 30.03 | 100 | 3,003 | Form 4 |
| P | John Colgrove | Insider | 04/23/2026 | Verkauf | 70.06 | 71,959 | 5,041,448 | Form 4 |
| PCRX | Shawn Cross | CFO | 04/22/2026 | Verkauf | 25.01 | 1,500 | 37,515 | Form 4 |
| PAHC | Jack Bendheim | CEO | 04/22/2026 | Verkauf | 54.29 | 7,040 | 382,202 | Form 4 |
| PB | Ned S Holmes | Director | 04/22/2026 | Verkauf | 69.86 | 500 | 34,930 | Form 4 |
| PB | Ned S Holmes | Director | 04/22/2026 | Verkauf | 69.85 | 600 | 41,910 | Form 4 |
| PAM | Marcos Marcelo Mindlin | Director | 04/22/2026 | Verkauf | 3.51 | 1,500,000 | 5,265,000 | Form 4 |
| PHVS | Anne Lesage | Insider | 04/22/2026 | Verkauf | 30.05 | 7,500 | 225,375 | Form 4 |
| PHVS | Anne Lesage | Insider | 04/22/2026 | Verkauf | 30.05 | 7,000 | 210,350 | Form 4 |
| PHVS | Johannes Gerardus Chri Schikan | Director | 04/22/2026 | Verkauf | 30.05 | 7,000 | 210,350 | Form 4 |
| PHVS | Peng Lu | Insider | 04/22/2026 | Verkauf | 30.05 | 7,001 | 210,380 | Form 4 |
| PMN | Patrick D Kirwin | Director | 04/22/2026 | Kauf | 11.33 | 4,000 | 45,320 | Form 4 |
| PENG | Anne Kuykendall | SVP | 04/22/2026 | Verkauf | 27.92 | 738 | 20,605 | Form 4 |
| P | John Colgrove | Insider | 04/22/2026 | Verkauf | 70.50 | 82,266 | 5,799,753 | Form 4 |
| PBI | Lauren Freemen-Bosworth | EVP | 04/21/2026 | Verkauf | 14.25 | 169 | 2,408 | Form 4 |
| PTCT | Matthew B Klein | CEO | 04/21/2026 | Verkauf | 70.91 | 2,850 | 202,094 | Form 4 |
| PCRX | Shawn Cross | CFO | 04/21/2026 | Verkauf | 25.01 | 2,845 | 71,153 | Form 4 |
| PLMR | Mac Armstrong | CEO | 04/21/2026 | Verkauf | 130.77 | 3,500 | 457,695 | Form 4 |
| PRLD | David P Bonita | Director | 04/21/2026 | Kauf | 4.44 | 2,815,315 | 12,499,999 | Form 4 |
| PRLD | Orbimed Advisors Llc | Director | 04/21/2026 | Kauf | 4.44 | 2,815,315 | 12,499,999 | Form 4 |
| PRCH | Matt Ehrlichman | CEO | 04/21/2026 | Verkauf | 8.12 | 121,242 | 984,485 | Form 4 |
| PRCH | Matthew Neagle | COO | 04/21/2026 | Verkauf | 8.12 | 62,801 | 509,944 | Form 4 |
| PRCH | Shawn Tabak | CFO | 04/21/2026 | Verkauf | 8.12 | 7,730 | 62,768 | Form 4 |
| P | John Colgrove | Insider | 04/21/2026 | Verkauf | 70.06 | 16,840 | 1,179,810 | Form 4 |
| PCRX | Shawn Cross | CFO | 04/20/2026 | Verkauf | 25.14 | 7,714 | 193,930 | Form 4 |
| PAM | Marcos Marcelo Mindlin | Director | 04/20/2026 | Verkauf | 3.43 | 1,250,000 | 4,287,500 | Form 4 |
| PTGX | Asif Ali | CFO | 04/20/2026 | Verkauf | 105.47 | 1,750 | 184,573 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).